Updated:
Shanghai Biren Technology shares fell in Hong Kong on Thursday, October 8, after the Chinese AI-chip maker announced a discounted placement of 130 million new H-shares to raise about HK$4.04 billion. Investing.com reported the stock down 8.2% at HK$31.62 during the session; a separate midday report put it at HK$31.58, down about 8.3%. The differing figures reflect the time of reporting.
The proposed issue price of HK$31.08 is 9.76% below Biren’s October 7 closing price of HK$34.44, and 13.73% below its five-session average. The discount and increase in the number of shares provide a direct explanation for the selling: investors must weigh the company’s planned funding against the dilution to existing shareholders and the price at which new shares are being offered.
Placement terms and potential dilution
Biren’s October 8 filing with the Hong Kong Stock Exchange says the placing agents will seek at least six independent investors for the new shares on a best-efforts basis. If the full allotment proceeds, it would represent about 5% of the company’s current total share capital and 4.76% of its enlarged share capital after issuance.
The proposed sale is expected to generate HK$4.0404 billion in gross proceeds and HK$4.0197 billion net of expenses. It is being made under a general mandate approved by shareholders in June, so a further shareholder vote is not required. However, the sale is conditional, including on Hong Kong exchange approval to list and trade the new shares; the filing cautions that the transaction may not proceed.
Where Biren says the money will go
The company has allocated about 70% of net proceeds to strategic supply-chain procurement, production preparation and commercialization of next-generation products. A further 20% is earmarked for research and development and improvements to its software ecosystem, while the remaining 10% is intended for working capital and general corporate purposes.
Biren’s board said the funding would support the company’s business needs and help secure upstream production capacity, shorten product launch timelines and advance customer validation. Those are company-stated aims; the filing does not establish that the financing will deliver those results or specify a revenue timetable for the next-generation products.
A second placement after July’s fundraising
The October deal follows a placement in July, when Biren issued 153 million new H-shares at HK$46.20 each, raising nearly HK$7.1 billion, according to contemporaneous coverage. Taken together, the two secondary offerings would bring the amount raised since Biren’s January 2026 Hong Kong listing to more than HK$11 billion, before considering the proceeds of the initial public offering.
Biren listed at HK$19.60 per share. Its shares rose sharply in the first half of the year, reaching a reported peak of HK$70.75, before retreating after the July placement. The October pricing is below that earlier placement price as well as the latest pre-announcement close, underscoring how the terms of successive capital raises have shifted with the share price.
What happens next
The placement agents are expected to place the shares with independent professional, institutional or other investors; Biren’s filing says no placee is expected to become a substantial shareholder as a result. The transaction remains subject to the stated conditions, including listing approval. The filing says unmet or unwaived conditions could terminate the agreement by 8 a.m. Hong Kong time on October 15, unless the parties agree to a later deadline.
A weak broader-market backdrop may also have weighed on sentiment. Investing.com reported the Hang Seng Index was down nearly 1% amid rising yields, while the separate placement coverage focused on the discounted issue as Biren’s company-specific catalyst. The available reports do not establish how much of the day’s decline was attributable to general market conditions rather than the placement.
